Sorrento Presents Preliminary Results of STI-2020 Against COVID-19
Shots: Following the US FDA’s approval, Gilead will screen healthy volunteers for P-I study this week and plans to initiate the study in patients with COVID-19 in Aug’2020. The therapy could be given to patients via nebulizer, which would allow for easier dosing outside the hospital and in earlier stages of the disease The inhaled […]Read More
